Keyword Suggestion
Domain Informations
Mozobil.com lookup results from whois.corporatedomains.com server:
- Domain created: 2004-09-07T21:57:53Z
- Domain updated: 2022-07-25T19:30:08Z
- Domain expires: 2024-09-07T21:57:53Z 0 Years, 141 Days left
- Website age: 19 Years, 223 Days
- Registrar Domain ID: 129423281_DOMAIN_COM-VRSN
- Registrar Url: http://cscdbs.com
- Registrar WHOIS Server: whois.corporatedomains.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: 8887802723
- Name server:
- NS1.SANOFI-SYNTHELABO.COM
- NS2.SANOFI-SYNTHELABO.COM
- NS3.SANOFI-SYNTHELABO.COM
- NS4.SANOFI-SYNTHELABO.COM
Network
- inetnum : 54.247.0.0 - 54.247.255.255
- name : AMAZON-DUB
- handle : NET-54-247-0-0-1
- status : Reallocated
- created : 2014-07-18
- changed : 2014-07-18
Owner
- organization : Amazon Data Services Ireland Limited
- handle : ADSIL-1
- address : Array,Dublin,D24,IE
Abuse
- handle : AEA8-ARIN
- name : Amazon EC2 Abuse
- phone : +1-206-555-0000
- email : [email protected]
Technical support
- handle : ANO24-ARIN
- name : Amazon EC2 Network Operations
- phone : +1-206-555-0000
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 54.247.151.159
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
Site Inspections
Port Scanner (IP: 54.247.151.159)
Spam Check (IP: 54.247.151.159)
Recent Searched Sites
› Atlanticstudio.cz (15 seconds ago) / CZ
› Zondahome.com (5 seconds ago) / US
› Channamereya.com (4 seconds ago) / US
› Mozobil.com (0 seconds ago) / IE
› Hwdesignnetwork.com (4 seconds ago) / US
› Symondsresearch.com (24 seconds ago) / US
› Medicalevents.com (21 seconds ago) / US
› Seed.kaiinos.com (8 seconds ago) / DK
› Whitwelllandscaping.com (3 seconds ago) /
› Repfinder.bausch.com (0 seconds ago) / US
› Space-engineers.com (1 mins ago) / US
› Irdp.gov.ao (4 seconds ago) / AO
› Avalon-instruments.com (12 seconds ago) / IT
› Cits2.com (19 seconds ago) / US
› Citrussprings.com (41 seconds ago) / CA
› Poconospa.adxpage.com (13 seconds ago) / US
› Komit.nu (15 seconds ago) / DK
› Outinvoice.com (8 seconds ago) / US
› Citrussuitessukhumvit.com (30 seconds ago) / SG
› Recentmissouricollisions.com (1 seconds ago) / US
Websites Listing
We found Websites Listing below when search with mozobil.com on Search Engine
MOZOBIL® (plerixafor) injection, for subcutaneous use …
Mozobil (plerixafor) injection is a sterile, preservative-free, clear, colorless to pale-yellow, isotonic solution for subcutaneous injection. Each mL of the sterile solution contains 20 mg of plerixafor. Each single-dose vial is filled to deliver 1.2 mL of the sterile solution that contains 24 mg of plerixafor and 5.9 mg of sodium chloride in Water for Injection adjusted to a pH of 6.0 to 7.5 ...
Products.sanofi.usSide Effects of Mozobil (Plerixafor Injection), Warnings, Uses
2021-11-03 · What Is Mozobil? Mozobil (plerixafor injection) is a hematopoietic stem cell mobilizer that helps bone marrow release stem cells into the bloodstream so they can be collected and transplanted back into the body, used in people with non-Hodgkin's lymphoma or multiple myeloma.. What Are Side Effects of Mozobil? Common side effects of Mozobil include …
Rxlist.comUniversity of Alberta Clinical Islet Transplant Program - Mozobil®
Stem cells are very young cells, which reside in the bone marrow, and they have the potential to differentiate into a number of cell types with different functions. By using a stem cell mobilizer (Plerixafor - Mozobil ®), stem cells are stimulated out of the bone marrow space, and mobilize into the bloodstream. Theoretically, these mobilized ...
Islet.caOur Patient Support Programs and COVID-19 - Sanofi in …
REACH PSP (Jevtana ®, Mozobil ® and Libtayo™): 1-855-572-6634 Renagel ® and Renvela ® Renassist Plus: 1-866-424-8051 Rilutek ® PSP: 1-866-474-5883. For any other product inquiries please contact Sanofi Canada Medical Information services at 1-800-265-7927.
Sanofi.caMoobil - Plerixafor uses, dose and side effects - zeepedia.com
2022-02-16 · Mozobil contains the active substance plerixafor, which blocks a protein on the surface of blood stem cells. This protein "binds" the blood stem cells to the bone marrow . Plerixafor improves the release of stem cells into the bloodstream (mobilization). The stem cells can then be collected by a machine that separates the blood components (apheresis machine) …
Zeepedia.comFILGRASTIM / PEGFILGRASTIM / PLERIXAFOR SPECIAL …
PLERIXAFOR (e.g. Mozobil) special authorization criteria "For the treatment of patients with NonHodgkin’s lymphoma (NHL) or multiple myeloma (MM) undergoing Peripheral Blood - Progenitor Cell (PBPC) collection and therapy, in combination with filgrastim, when prescribed by a designated prescriber." Coverage may be approved for a maximum of four doses …
Ab.bluecross.caموبيزل - كل ما يخص عالم الموبايلات
موقع موبيزل يختص بتقديم كل ما هو جديد في عالم الموبايلات حيث نعرض مواصفات واسعار ومراجعات ...
Mobizil.comNew treatment now available for patients with Non-Hodgkins
2012-05-09 · Pr Mozobil™ provides enhanced mobilization of stem cells for autologous transplantation in Non-Hodgkin's Lymphoma and Multiple Myeloma patients. MONTRÉAL, May 9, 2012 /CNW/ - Sanofi Canada ...
Newswire.caMozobil 20 mg/ml solution for injection - Summary of Product ...
2021-05-10 · 1. Name of the medicinal product. Mozobil 20 mg/ml solution for injection. 2. Qualitative and quantitative composition. One ml of solution contains 20 mg plerixafor. Each vial contains 24 mg plerixafor in 1.2 ml solution. Excipients with known effect: Each ml contains approximately 5 mg (0.2 mmol) of sodium.
Medicines.org.ukHIGHLIGHTS OF PRESCRIBING INFORMATION - Sanofi
Safety data for Mozobil in combination with G-CSF were obtained from two randomized placebo-controlled studies (301 patients) and 10 uncontrolled studies (242 patients). Patients were primarily treated with Mozobil at daily doses of 0.24 mg/kg SC. Median exposure to Mozobil in these studies was 2 days (range 1 to 7 days).
Products.sanofi.usLogin
Login. This website is intended exclusively for Southern Africa healthcare professionals only. Home. Login.
Campus.sanofiFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 2 …
Were primarily treated with Mozobil at daily doses of 0.24 mg/kg SC. Median exposure to Mozobil in these studies was 2 days (range 1 to 7 days). In the two randomized studies in patients with NHL and MM, a total of 301 patients were treated in the Mozobil and G-CSF group and 292 patients were treated in the placebo and G-CSF group.
Accessdata.fda.govMozobil - Uniprix
Produits de santé et beauté, service photos, médicaments, conseils santé, circulaires, concours.
Uniprix.comMozobil - Side Effects, Interactions, Uses, Dosage, Warnings
Find everything you need to know about Mozobil, including what it is used for, warnings, reviews, side effects, and interactions. Learn more about Mozobil at EverydayHealth.com.
Everydayhealth.comMozobil | Prescription Discount Pricing - OptionRx
Mozobil is a prescription-only medication that is used to collect stem cells within the bloodstream. When taken, Mozobil releases hematopoietic stem cells from the bone marrow into the bloodstream to allow easy collection in patients diagnosed with non-Hodgkin’s lymphoma or multiple myeloma.
Optionrx.comRevision Date: December 2008 Proprietary and Confidential Page 1
Treated with Mozobil at daily doses of 0.24 mg/kg SC. Median exposure to Mozobil in these studies was 2 days (range 1 to 7 days). In the two randomized studies in patients with NHL and MM, a total of 301 patients were treated in the Mozobil and G-CSF group and 292 patients were treated in the placebo and G-CSF group. Patients received daily ...
Accessdata.fda.govDailyMed - MOZOBIL- plerixafor injection, solution
2018-11-26 · Mozobil (plerixafor) injection is a sterile, preservative-free, clear, colorless to pale-yellow, isotonic solution for subcutaneous injection. Each mL of the sterile solution contains 20 mg of plerixafor. Each single-dose vial is filled to deliver 1.2 mL of the sterile solution that contains 24 mg of plerixafor and 5.9 mg of sodium chloride in Water for Injection adjusted to a pH of 6.0 to …
Dailymed.nlm.nih.gov
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| pagemodified.com | namecheap.com | 2 Years, 209 Days |
| searchengine.com | godaddy.com | -1 Years, -139 Days |
| cecilathletics.com | godaddy.com | -1 Years, -138 Days |
| unitedwayelpaso.org | networksolutions.com | -2 Years, -46 Days |
| disetti.com | godaddy.com | 1 Year, 45 Days |
| patwie.com | namecheap.com | 3 Years, 276 Days |
| pictufy.com | domain.com | -2 Years, -23 Days |
| gas-kvas.com | namesilo.com | 140 Days |
| ogorodnik.info | publicdomainregistry.com | 29 Days |
| minneapolis2040.com | domains.google.com | -1 Years, -105 Days |